标题
Outcomes with Finerenone in Participants with Stage 4 CKD and Type 2 Diabetes
作者
关键词
-
出版物
Clinical Journal of the American Society of Nephrology
Volume Publish Ahead of Print, Issue -, Pages -
出版商
Ovid Technologies (Wolters Kluwer Health)
发表日期
2023-03-17
DOI
10.2215/cjn.0000000000000149
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Empagliflozin in Patients with Chronic Kidney Disease
- (2022) NEW ENGLAND JOURNAL OF MEDICINE
- Cardiovascular Disease in Chronic Kidney Disease
- (2021) Joachim Jankowski et al. CIRCULATION
- Effects of Dapagliflozin in Stage 4 Chronic Kidney Disease
- (2021) Glenn M. Chertow et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Cardiovascular Events with Finerenone in Kidney Disease and Type 2 Diabetes
- (2021) Bertram Pitt et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mineralocorticoid Receptor Antagonism in Chronic Kidney Disease
- (2021) Panagiotis I. Georgianos et al. Kidney International Reports
- Novel non‐steroidal mineralocorticoid receptor antagonists in cardiorenal disease
- (2021) Ulrich Kintscher et al. BRITISH JOURNAL OF PHARMACOLOGY
- Cardiovascular and kidney outcomes with finerenone in patients with type 2 diabetes and chronic kidney disease: the FIDELITY pooled analysis
- (2021) Rajiv Agarwal et al. EUROPEAN HEART JOURNAL
- Hyperkalemia Risk with Finerenone: Results from the FIDELIO-DKD Trial
- (2021) Rajiv Agarwal et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- Mineralocorticoid Receptor Antagonists in Diabetic Kidney Disease
- (2021) Daiji Kawanami et al. Frontiers in Pharmacology
- Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine
- (2020) Rajiv Agarwal et al. EUROPEAN HEART JOURNAL
- Dapagliflozin in Patients with Chronic Kidney Disease
- (2020) Hiddo J.L. Heerspink et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes
- (2020) George L. Bakris et al. NEW ENGLAND JOURNAL OF MEDICINE
- Effects of Canagliflozin in Patients with Baseline eGFR
- (2020) George Bakris et al. Clinical Journal of the American Society of Nephrology
- Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy
- (2019) Vlado Perkovic et al. NEW ENGLAND JOURNAL OF MEDICINE
- Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
- (2019) Hertzel C Gerstein et al. LANCET
- Semaglutide and Cardiovascular Outcomes in Patients with Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
- (2016) Steven P. Marso et al. NEW ENGLAND JOURNAL OF MEDICINE
- Progression to Stage 4 chronic kidney disease and death, acute kidney injury and hospitalization risk: a retrospective cohort study
- (2015) Maneesh Sud et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Primary Care Detection of Chronic Kidney Disease in Adults with Type-2 Diabetes: The ADD-CKD Study (Awareness, Detection and Drug Therapy in Type 2 Diabetes and Chronic Kidney Disease)
- (2014) Lynda A. Szczech et al. PLoS One
- Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
- (2013) Ron T Gansevoort et al. LANCET
- Estimation of treatment effect under non-proportional hazards and conditionally independent censoring
- (2012) Adam P. Boyd et al. STATISTICS IN MEDICINE
- The Frequency of Hyperkalemia and Its Significance in Chronic Kidney Disease
- (2009) Lisa M. Einhorn et al. ARCHIVES OF INTERNAL MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation